Skip to main content
. Author manuscript; available in PMC: 2018 Oct 1.
Published in final edited form as: Clin Cancer Res. 2018 Jan 4;24(7):1654–1666. doi: 10.1158/1078-0432.CCR-17-2168

Figure 6. Combination surgery, fractionated irradiation, and post-irradiation gemcitabine therapy.

Figure 6

Bioluminescence measures of tumor growth (A) and survival curves (B) of mice with mSEP-CR(+) treated with surgery and radiation alone or surgery, radiation and 3 hour infusions of gemcitabine. Bioluminescence measures of tumor growth (C) and survival curves (D) of mice with mCPC treated with surgery and 3 hour infusions of gemcitabine alone or surgery and gemcitabine. Figures in paraenthesis in bioluminescence plots are the days (d) when treated tumor volume was significantly (p<0.05, non-parametric) less than control.